PHP
SDGR icon

Parkman Healthcare Partners’s Schrodinger SDGR Stock Holding History

Parkman Healthcare Partners’s Portfolio SDGR Stock Details SDGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-298,939
Closed -$5.35M – 108
2025
Q4 		$5.35M Sell
298,939
-41,248
-12% -$782K 0.51% 59
2025
Q3 		$6.82M Sell
340,187
-247,369
-42% -$4.97M 0.71% 53
2025
Q2 		$11.8M Buy
587,556
+106,086
+22% +$2.42M 1.36% 25
2025
Q1 		$9.5M Sell
481,470
-81,621
-14% -$1.84M 1.13% 33
2024
Q4 		$10.9M Buy
563,091
+3,986
+0.7% +$77.4K 1.45% 24
2024
Q3 		$10.4M Sell
559,105
-162,268
-22% -$3.33M 1.32% 24
2024
Q2 		$14M Sell
721,373
-278,641
-28% -$6.42M 1.87% 14
2024
Q1 		$27M Buy
1,000,014
+594,782
+147% +$16.6M 3.31% 5
2023
Q4 		$14.5M Buy
405,232
+36,578
+10% +$1.06M 2.04% 16
2023
Q3 		$10.4M Sell
368,654
-113,972
-24% -$4.59M 1.91% 12
2023
Q2 		$24.1M Buy
482,626
+83,456
+21% +$2.82M 4.18% 3
2023
Q1 		$10.5M Buy
399,170
+171,219
+75% +$4.07M 2.29% 9
2022
Q4 		$4.26M Buy
227,951
+104,272
+84% +$2.16M 1.13% 35
2022
Q3 		$3.09M Buy
123,679
+1,454
+1% +$42.7K 0.88% 43
2022
Q2 		$3.23M Buy
122,225
+6,334
+5% +$170K 1.19% 26
2022
Q1 		$3.95M Buy
115,891
+48,099
+71% +$1.46M 1.16% 31
2021
Q4 		$2.36M Buy
67,792
+34,684
+105% +$1.58M 0.52% 53
2021
Q3 		$1.81M Buy
33,108
+2,500
+8% +$160K 0.46% 57
2021
Q2 		$2.31M Sell
30,608
-9,845
-24% -$714K 0.51% 54
2021
Q1 		$3.09M Sell
40,453
-115,632
-74% -$10.4M 0.72% 44
2020
Q4 		$12.4M Buy
156,085
+106,085
+212% +$6.67M 3.17% 4
2020
Q3 		$2.38M Buy
50,000
+35,000
+233% +$2.41M 0.63% 53
2020
Q2 		$1.37M Sell
15,000
-65,071
-81% -$3.79M 0.39% 64
2020
Q1 		$3.45M Buy
+80,071
New +$3.02M 1.6% 23

Other funds holding SDGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Gates Foundation Trust
Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parkman Healthcare Partners's SDGR Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Schrodinger (SDGR) in Q1 2026, closing a stake of 298,939 shares — an estimated $5.35M sold.

Parkman Healthcare Partners first reported a position in SDGR in Q1 2020 and held it in 24 quarters. The position peaked at $27M in Q1 2024. 227 funds tracked by Wall St. Rank hold SDGR as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining Schrodinger position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 298,939 Schrodinger shares in Q1 2026, an estimated $5.35M.
  • Parkman Healthcare Partners first reported a position in Schrodinger in Q1 2020 and held it in 24 quarters.
  • Parkman Healthcare Partners's Schrodinger position peaked at $27M in Q1 2024.
  • 227 funds tracked by Wall St. Rank held Schrodinger as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.